India Will Manufacture Johnson And Johnson’s COVID Vaccine: What We Know So Far
In a move that could benefit India and other countries in the fight against the COVID-19 pandemic, New Delhi will manufacture Johnson & Johnson’s single-dose coronavirus vaccine as part of the initiative of the Quad group of countries.
According to The Times of India, the project will be financed by Japan and US, while Australia will use its logistics capability to ship the vaccines to Southeast Asia and Pacific countries.
What is QUAD summit??
The Quadrilateral Security Dialogue is an informal strategic forum between the United States, Japan, India and Australia that is maintained by semi-regular summits, information exchanges and military drills between member countries.
The development came in the first Quad summit between Narendra Modi, Joe Biden, Yoshihide Suga and Scott Morrison.
The report further added that this only the first of the vaccines and more will be added to this initiative.
This comes as the vaccine, the first single-shot COVID-19 vaccine so far has been getting clearance for use around the world.
The European Union on Thursday authorised the use of the vaccine after the bloc's medical regulator gave its approval.
"More safe and effective vaccines are coming to the market," EU Commission President Ursula von der Leyen said in a tweet.
EU's medicines regulator has approved the single-shot Johnson & Johnson coronavirus vaccine.
"We have just authorised the use of Johnson & Johnson's vaccine in the EU.... With the number of doses we ordered, we could vaccinate up to 200 million people in the EU" with the J&J jab this year, she said.
US was the first to approve the use of the vaccine in the country.
Earlier this month the US government had brokered a deal between Johnson & Johnson and Merck, a leading vaccine maker, who failed in its efforts to make its own vaccines to use the latter's manufacturing facility.
